Indian drug companies start off a price war on experimental Covid-19 drug
Over the next few weeks, close to 10 drug companies including Abbott,
Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr
Reddy's Laboratories are expected to launch their own brands of
favipiravir, despite inconclusive evidence of its effectiveness.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-drug-companies-start-off-a-price-war-on-experimental-covid-19-drug/articleshow/77156304.cms
Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr
Reddy's Laboratories are expected to launch their own brands of
favipiravir, despite inconclusive evidence of its effectiveness.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-drug-companies-start-off-a-price-war-on-experimental-covid-19-drug/articleshow/77156304.cms
Comments
Post a Comment